Cargando…
Dopamine and cAMP‐regulated phosphoprotein 32kDa (DARPP‐32), protein phosphatase‐1 and cyclin‐dependent kinase 5 expression in ovarian cancer
Dopamine and cyclic‐AMP activated phosphoprotein Mr32kDa (DARPP‐32) is a central signalling protein in neurotransmission. Following DARPP‐32 phosphorylation by protein kinase A (PKA), DARPP‐32 becomes a potent protein phosphatase 1 (PP1) inhibitor. DARPP‐32 can itself inhibit PKA following DARPP‐32...
Autores principales: | Martin, Stewart G., Zhang, Siwei, Yang, Song, Saidy, Behnaz, Deen, Suha, Storr, Sarah J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417681/ https://www.ncbi.nlm.nih.gov/pubmed/32588513 http://dx.doi.org/10.1111/jcmm.15553 |
Ejemplares similares
-
Dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression
por: Kotecha, Shreeya, et al.
Publicado: (2019) -
Deciphering the Actions of Antiparkinsonian and Antipsychotic Drugs on cAMP/DARPP-32 Signaling
por: Bonito-Oliva, Alessandra, et al.
Publicado: (2011) -
Unravelling transcriptomic complexity in breast cancer through modulation of DARPP-32 expression and signalling pathways
por: Saidy, Behnaz, et al.
Publicado: (2023) -
PP1, PKA and DARPP‐32 in breast cancer: A retrospective assessment of protein and mRNA expression
por: Saidy, Behnaz, et al.
Publicado: (2021) -
DARPP-32: from neurotransmission to cancer
por: Belkhiri, Abbes, et al.
Publicado: (2016)